Fig. 3From: Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort studyOverall survival rates of the patients with S-1 (A) and capecitabine/oxaliplatin (B) according to cyclesBack to article page